Reflection and future of immunotherapy for type 1 diabetes mellitus / 中国医师杂志
Journal of Chinese Physician
;
(12): 4-6, 2019.
Artigo
em Chinês
| WPRIM
| ID: wpr-734054
ABSTRACT
Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease with an increasing prevalence and affects quality of life.Daily insulin replacement therapy is not a radical treatment.With the progress of the disease course,it is often accompanied by a variety of complications and has a high rate of disability and mortality.Many breakthroughs have been made in the prevention and treatment of type 1 diabetes through immune intervention,but clinical trials that have always failed to achieve the desired results have led scientists to rethink where immunotherapy should go in the future.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Journal of Chinese Physician
Ano de publicação:
2019
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS